This company has had a recurring nightmare dodging the lumpy revenue syndrome. Selling bundles of patents will do nothing to remedy that, in fact it will make it more profound.
I do not see any synergy gained on the portfolio as a whole selling parts of the portfolio. Nice try for your usual spin.
Merritt is panicking to save his sorry arse. He better improve his band-aid routine by the ASM, or you see a sell off much worse than we have seen so far.
Market Data 
Markets 
AI
